Duvaraka Kula-Alwar Selected Research

Ischemia

12/2022	Cyclophilin D knockout mice do not accumulate succinate during cardiac ischemia.
1/2022	Ischemia-Selective Cardioprotection by Malonate for Ischemia/Reperfusion Injury.
1/2022	Ester Prodrugs of Malonate with Enhanced Intracellular Delivery Protect Against Cardiac Ischemia-Reperfusion Injury In Vivo.
1/2021	Structural basis for a complex I mutation that blocks pathological ROS production.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Duvaraka Kula-Alwar Research Topics

Disease

4	Ischemia 12/2022 - 01/2021
3	Reperfusion Injury 01/2022 - 12/2019
1	Myocardial Infarction 01/2022
1	Infarction (Infarctions) 01/2022

Drug/Important Bio-Agent (IBA)

4	Succinic Acid (Succinate)IBA 12/2022 - 12/2019
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2022 - 01/2022
2	malonic acid (malonate)IBA 01/2022 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2021
1	Cyclophilins (Cyclophilin)IBA 12/2022
1	ProdrugsIBA 01/2022
1	EstersIBA 01/2022

Therapy/Procedure

1	Ligation 01/2022